TherapeuticsMD Overview
- Founded
-
2008
- Status
-
Public
- Employees
-
309
- Stock Symbol
-
TXMD
- Investments
-
3
- Share Price
-
$9.29
- (As of Friday Closing)
TherapeuticsMD General Information
Description
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.
Contact Information
Website
www.therapeuticsmd.com
Formerly Known As
AMHN
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- 951 Yamato Road
- Suite 220
- Boca Raton, FL 33431
- United States
+1 (561) 000-0000
TherapeuticsMD Timeline
TherapeuticsMD Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $9.29 | $8.90 | $1.99 - $49.00 | $87.1M | 9.4M | 1.52M | -$21.69 |
TherapeuticsMD Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 297,274 | 241,185 | 531,446 | 706,022 |
| Revenue | 86,418 | 86,951 | 64,872 | 49,647 |
| EBITDA | (157,367) | (145,747) | (153,408) | (158,227) |
| Net Income | (182,053) | (172,415) | (183,524) | (176,145) |
| Total Assets | 133,381 | 169,472 | 181,610 | 265,986 |
| Total Debt | 212,123 | 197,693 | 248,627 | 205,281 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
TherapeuticsMD Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TherapeuticsMD Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusiv
Pharmaceuticals
Boca Raton, FL
309
As of 2022
00000
000000000
00000
000000
olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
000000000000000
Herndon, VA
000000
ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000 000000000
Henderson, NV
000
As of 0000
00000
000000 - 000
00000
Add Comparison
TherapeuticsMD Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ascend Therapeutics (Besins Healthcare) | Corporation | Herndon, VA | ||||
| 00000000 000000000 | Corporation | Henderson, NV | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000&0 | 00000 |
| 000000000000000 00 | Corporation | Lagos, Nigeria | 00 | |||
| 00000000 000000000 | Formerly PE-Backed | Orlando, FL | 000 | 000000&0 |
TherapeuticsMD Patents
TherapeuticsMD Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210244747-A1 | Steroid hormone pharmaceutical formulations | Pending | 07-Feb-2020 | 0000000000 | |
| US-20190022107-A1 | Vaginal inserted estradiol pharmaceutical compositions and methods | Abandoned | 08-Jun-2017 | 0000000000 | |
| AU-2018280270-A1 | Vaginal inserted estradiol pharmaceutical compositions and methods | Pending | 08-Jun-2017 | 0000000000 | |
| US-20180280410-A1 | Natural combination hormone replacement formulations and therapies | Abandoned | 03-Apr-2017 | 0000000000 | |
| US-20190247401-A1 | Natural combination hormone replacement formulations and therapies | Abandoned | 03-Apr-2017 | A61K31/566 |
TherapeuticsMD Executive Team (19)
TherapeuticsMD Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Angus Russell | TherapeuticsMD | Board Member | 000 0000 |
| Cooper Collins | Self | Board Member | 000 0000 |
| Gail Naughton Ph.D | TherapeuticsMD | Board Member | 000 0000 |
| Hugh O'Dowd | TherapeuticsMD | Chief Executive Officer & Board Member | 000 0000 |
| Jules Musing | TherapeuticsMD | Board Member | 000 0000 |
TherapeuticsMD Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
TherapeuticsMD Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
TherapeuticsMD Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 04-Oct-2011 | 0000000000 | 00.000 | Biotechnology | 000000 00 |
| 00000000 0000 | 11-Jun-2010 | 0000000000 | 00000 | Other Healthcare Services | |
| Croff Enterprises | 27-Jul-2009 | Merger/Acquisition | 000.00 | Holding Companies |
TherapeuticsMD Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000000 | Biotechnology | Boca Raton, FL | 0000 |
TherapeuticsMD Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 000000 00 | 11-Jun-2010 | 000000000000000000 | 00000 | Completed |
|